Prophylactic Use of Entecavir for Lymphoma Patients With Past Hepatitis B Virus Infection: A Randomized Controlled Trial
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 19 (2) , 103-108
Abstract
No abstract availableKeywords
Funding Information
- CSCO (Y-Q2017-035)
- Scientific Research Fund for the Treatment of Chronic Anemia in China (LIM-SS-16001)
- Capital Funds for Health Improvement and Research (2018-1-2151)
- Beijing Municipal Administration of Hospitals (XMLX201502)
This publication has 26 references indexed in Scilit:
- The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapyLeukemia & Lymphoma, 2014
- Management of patients with hepatitis B who require immunosuppressive therapyNature Reviews Gastroenterology & Hepatology, 2013
- Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective studyHepatology, 2013
- Hepatitis B, Rituximab, Screening, and Prophylaxis: Effectiveness and Cost EffectivenessJournal of Clinical Oncology, 2012
- Hepatitis B Virus Screening Before Chemotherapy for Lymphoma: A Cost-Effectiveness AnalysisJournal of Clinical Oncology, 2012
- American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant DiseasesJournal of Clinical Oncology, 2010
- Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapyCancer, 2009
- Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccinationVaccine, 2009
- Chronic hepatitis B: Update 2009 #Hepatology, 2009
- Reactivation of hepatitis B # †Hepatology, 2009